Key Regulatory Issues for Dengue Vaccine Development

Article

In this week's PLoS Medicine, Richard Mahoney and colleagues discuss two recent meetings convened by the Pediatric Dengue Vaccine Initiative and the Developing Countries' Vaccine Regulators Network on regulatory issues that need to be addressed before licensing dengue vaccines.

This work was supported by Bill & Melinda Gates Foundation grant# 23197. The

Reference: Mahoney R, Chocarro L, Southern J, Francis DP, Vose J, et al. (2011) Dengue Vaccines Regulatory Pathways: A Report on Two Meetings with Regulators of Developing Countries. PLoS Med 8(2): e1000418.doi:10.1371/journal.pmed.1000418

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
COVID-19 infection (Adobe Stock327378972 by rost9)
Swarm of Mosquitoes on Green Background Disease Carriers Insect Infestation  (Adobe Stock 1609688034 by Amith)
Structural detail of Hepatitis B virus on blue-green background. 3D illustration (Adobe Stock 239268660 by Destina)
© 2025 MJH Life Sciences

All rights reserved.